Puthanakit, T., Huang, L.-M., Chiu, C.-H., Tang, R.-B., Schwarz, T.F., Esposito, S., Frenette, L., Giaquinto, C., Mc Neil, S., Rheault, P., Durando, P., Horn, M., Klar, M., Poncelet, S., De Simoni, S., Friel, D., De Muynck, B., Suryakiran, P.V., Hezareh, M., Descamps, D., Thomas, F. und Struyf, F. (2025) Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15–25 years [cd]. Freiburg: Universität. doi:10.1093 nfdis/jiw036.

Puthanakit, Thanyawee, Li-Min Huang, Cheng-Hsun Chiu, Ren-Bin Tang, Tino F. Schwarz, Susanna Esposito, Louise Frenette, Carlo Giaquinto, Shelly Mc Neil, Paul Rheault, Paolo Durando, Michael Horn, Maximilian Klar, Sylviane Poncelet, Stéphanie De Simoni, Damien Friel, Benoit De Muynck, Pemmaraju V. Suryakiran, Marjan Hezareh, Dominique Descamps, Florence Thomas, und Frank Struyf. Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15–25 years. Cd. Freiburg: Universität, [2025?], Freiburg: Universität, [2025?]. https://doi.org/10.1093 nfdis/jiw036.

Puthanakit, T., Huang, L.-M., Chiu, C.-H., Tang, R.-B., Schwarz, T. F., Esposito, S., Frenette, L., Giaquinto, C., Mc Neil, S., Rheault, P., Durando, P., Horn, M., Klar, M., Poncelet, S., De Simoni, S., Friel, D., De Muynck, B., Suryakiran, P. V., Hezareh, M., Descamps, D., Thomas, F., & Struyf, F. (ca. 2025). Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15–25 years [Cd]. Universität. https://doi.org/10.1093 nfdis/jiw036

Puthanakit, T., L.-M. Huang, C.-H. Chiu, R.-B. Tang, T. F. Schwarz, S. Esposito, L. Frenette, C. Giaquinto, S. Mc Neil, P. Rheault, P. Durando, M. Horn, M. Klar, S. Poncelet, S. De Simoni, D. Friel, B. De Muynck, P. V. Suryakiran, M. Hezareh, D. Descamps, F. Thomas, und F. Struyf. Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15–25 years. cd, Universität, 2025, https://doi.org/10.1093 nfdis/jiw036.

PUTHANAKIT, Thanyawee, Li-Min HUANG, Cheng-Hsun CHIU, Ren-Bin TANG, Tino F. SCHWARZ, Susanna ESPOSITO, Louise FRENETTE, Carlo GIAQUINTO, Shelly MCNEIL, Paul RHEAULT, Paolo DURANDO, Michael HORN, Maximilian KLAR, Sylviane PONCELET, Stéphanie DE SIMONI, Damien FRIEL, Benoit DE MUYNCK, Pemmaraju V. SURYAKIRAN, Marjan HEZAREH, Dominique DESCAMPS, Florence THOMAS und Frank STRUYF, 2025. Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years versus a 3-dose regimen in women aged 15–25 years. Freiburg: Universität